Pauline Riviere
Pessac-sur-dordogne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials.
Journal: Gut
Published: April 12, 2026
Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: February 12, 2026
Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025
TRAKJAK: a complete blood count-based prediction of polycythemia vera at initial erythrocytosis workup to reduce financial and ecological costs.
Journal: The American journal of medicine
Published: June 25, 2025
Real-World Effectiveness of Advanced Therapies in Microscopic Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 20, 2025
Overlap of Esophageal Disorders of Gut-Brain Interactions and Gastroesophageal Reflux Disease Is Highly Prevalent in Patients With Refractory Reflux Symptoms.
Journal: The American journal of gastroenterology
Published: February 25, 2025
Systematic review: severe endoscopic lesions in inflammatory bowel disease.
Journal: Journal of Crohn's & colitis
Published: February 19, 2025
Adherence to home parenteral nutrition and/or intravenous fluid infusions in patients with chronic intestinal failure: A multicenter cross-sectional study.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: January 21, 2025
Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience.
Journal: Alimentary pharmacology & therapeutics
Published: December 31, 2024
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 26, 2024
Persistence of subcutaneous versus intravenous infliximab in a real-life cohort: A propensity-score matched comparative analysis.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 19, 2024
Last Updated: 09/26/2026